Nat. Genet. 41, 1345–1349 (2009); published online 8 November 2009; corrected after print 21 March 2013
In the version of this article initially published, the units for treatment duration in Table 1 were incorrectly given as weeks rather than months. This error has been corrected in the HTML and PDF versions of the article.
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1038/ng.478
Rights and permissions
About this article
Cite this article
Ross, C., Katzov-Eckert, H., Dubé, MP. et al. Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 45, 578 (2013). https://doi.org/10.1038/ng.0513-578
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.0513-578
This article is cited by
-
Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
Clinical Pharmacology & Therapeutics (2013)
-
Genetics of Cisplatin Ototoxicity: Confirming the Unexplained?
Clinical Pharmacology & Therapeutics (2013)
